Ignitium, LLC – Trademark Portfolio

Entity Type: 16

Ignitium, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include IGNITIUM, ABX ORCHESTRATION, and ENLIGHTIUM ACADEMY. The owner is based in Spokane, WA.

601 W. Riverside Ave. Suite 1700

Spokane, WA 99201

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ignitium, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Ignitium, LLC have?

Ignitium, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 cancelled.

What trademark classes does Ignitium, LLC file in?

Ignitium, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What are Ignitium, LLC's most well-known trademarks?

Ignitium, LLC's registered trademark portfolio includes well-known marks such as IGNITIUM, ABX ORCHESTRATION, and ENLIGHTIUM ACADEMY. These are among 3 currently registered trademarks in the portfolio.

What is Ignitium, LLC's trademark registration success rate?

Ignitium, LLC has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.